Key result
A compliance reminder device was assessed positively by 78% of patients and 83% of physicians, with 64% of patients wishing to continue using it.
Why the study?
Does a compliance reminder device have high acceptance among patients and physicians in the treatment of hypertension?
Cross-Sectional (n=1,194)
Does a compliance reminder device have high acceptance among patients and physicians in the treatment of hypertension?
A compliance reminder device was well accepted by a majority of patients and physicians, suggesting its potential utility in supporting adherence to chronic antihypertensive therapy.
Answers are grounded in this paper and cite their sources.
High acceptance of compliance reminder device in hypertension; leaves open effects on adherence or outcomes in prospective trials.
Low compliance to therapeutic regimens can have serious impact on patient health. A variety of technologies such as tablet dispensers and reminders has been developed to improve compliance. The aim of this study was to assess the acceptance of patients and physicians with regard to the functions and usefulness of a reminder device. The respondents were participants in a trial evaluating antihypertensive medical treatment. Patients and treating physicians received a self-administered questionnaire to evaluate the device; 1194 patients and their physicians completed the questionnaire. Seventy-three per cent of patients stated that they always or mostly used the device. Overall, 78% of patients and 83% of physicians assessed the device positively. The reminder and feedback functions were assessed similarly. Sixty-four per cent of the patients stated that they would like to continue to use the device, as did 71% of the physicians. The reminder device was well accepted by a majority of patients and physicians in this study. Acceptance is an important factor for such a device to be used in everyday life and a majority of respondents wanted to continue using it. The current device could be a major help for patients on chronic medication therapy in a variety of therapies.
No takes yet. Share an insight, caveat, or question.
Christensen et al. (2009) conducted a cross-sectional in Hypertension (n=1,194). Compliance reminder device was evaluated on Positive assessment of the device by patients. A compliance reminder device was assessed positively by 78% of patients and 83% of physicians, with 64% of patients wishing to continue using it.
Synapse has enriched 10 related papers. Consider them for comparative context: